"Global Drug Discovery Services Market – Industry Trends and Forecast to 2030

Global Drug Discovery Services Market, By Type (Medicinal Chemistry Services, Biology Services, Drug Metabolism and Pharmacokinetics), Process (Target Validation, Target Selection, Hit-To-Lead Identification, Candidate Validation, Lead Optimization), Drug Type (Biologics, Small Molecules), Therapeutic Area (Neurology, Diabetes, Oncology, Respiratory Diseases, Cardiovascular Diseases, Others) – Industry Trends and Forecast to 2030.

Access Full 350 Pages PDF Report @

https://www.databridgemarketresearch.com/reports/global-drug-discovery-services-market

Data Bridge Market Research analyses that the drug discovery services market, which was USD 14.68 billion in 2022, is expected to reach USD 44.91 billion by 2030, at a CAGR of 15.00% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

**Segments**

- **By Type**: The drug discovery services market can be segmented by type into chemistry services, biology services, lead identification and screening services, lead optimization services, preclinical services, and others. Chemistry services include medicinal chemistry, custom synthesis, and analytical chemistry. Biology services encompass target validation, assay development, cellular and molecular biology, and animal models. Lead identification and screening services involve high-throughput screening (HTS) and target identification. Lead optimization services focus on improving the properties of identified leads. Preclinical services cover in vivo and in vitro testing.

- **By Process**: The market can be segmented by process into target selection, hit-to-lead identification, lead optimization, and candidate validation. Target selection involves identifying disease targets for drug development. Hit-to-lead identification is the process of identifying potential leads that can become drug candidates. Lead optimization focuses on enhancing the properties of selected leads to improve their chances of success. Candidate validation involves verifying the efficacy and safety of the final drug candidate.

- **By End User**: The drug discovery services market can also be segmented by end user into pharmaceutical and biopharmaceutical companies, contract research organizations (CROs), academic and research institutes, and others. Pharmaceutical and biopharmaceutical companies are the primary users of drug discovery services due to their focus on developing new drugs. CROs provide specialized services to support drug discovery efforts. Academic and research institutes are involved in early-stage research and collaborations with industry players.

**Market Players**

- **Thermo Fisher Scientific Inc.**: A leading provider of drug discovery services offering a wide range of solutions for various stages of the drug discovery process.

- **Charles River Laboratories International, Inc.**: Another key player in the market providing preclinical and discovery services to support drug development.

- **Eurofins Scientific**: A prominent player offering a comprehensive suite of drug discovery services including in vitro testing and bioanalytical services.

- **Evotec AG**: Specializes in integratedThermo Fisher Scientific Inc. is a dominant player in the drug discovery services market, known for its extensive range of solutions covering various stages of the drug discovery process. The company's comprehensive services encompass chemistry, biology, lead identification, preclinical testing, and more, catering to the diverse needs of pharmaceutical and biopharmaceutical companies, CROs, and research institutions. Thermo Fisher's expertise in medicinal chemistry, custom synthesis, assay development, and in vivo testing positions it as a preferred partner for drug discovery initiatives globally. With a strong emphasis on innovation and technology, Thermo Fisher continuously invests in research and development to enhance its service offerings and stay at the forefront of the market.

Charles River Laboratories International, Inc. is another key player shaping the drug discovery services landscape with its focus on preclinical and discovery services. The company's specialized offerings in target validation, animal models, and bioanalytical services cater to the critical needs of drug development programs, enabling clients to accelerate their research and decision-making processes. Charles River's strong reputation for quality and reliability has established it as a trusted partner for pharmaceutical companies seeking comprehensive support for their drug discovery projects. By leveraging its expertise in predictive toxicology, pharmacology, and safety assessment, Charles River plays a vital role in advancing drug development efforts and ensuring regulatory compliance across the industry.

Eurofins Scientific has emerged as a prominent player in the drug discovery services market, known for its diverse portfolio of in vitro testing and bioanalytical services. The company's wide range of offerings includes ADME-Tox studies, biomarker analysis, drug metabolism testing, and pharmacokinetic profiling, providing valuable insights to support drug discovery and development activities. Eurofins' strong focus on scientific excellence and customer satisfaction has earned it a reputation for delivering high-quality, reliable services to pharmaceutical clients worldwide. By continuously expanding its capabilities and investing in cutting-edge technologies, Eurofins remains well positioned to meet the evolving needs of the drug discovery market and support the quest for**Global Drug Discovery Services Market**

- **Medicinal Chemistry Services**: This segment plays a crucial role in drug discovery by designing and synthesizing chemical compounds with potential therapeutic properties. Medicinal chemistry services involve the optimization of lead compounds to enhance their efficacy and safety profiles.

- **Biology Services**: Biology services in the drug discovery process encompass a wide range of activities such as target validation, assay development, and animal model testing. These services are instrumental in identifying and validating drug targets, as well as understanding the biological mechanisms of action.

- **Drug Metabolism and Pharmacokinetics (DMPK)**: DMPK studies are essential for evaluating the absorption, distribution, metabolism, and excretion of drug candidates. Drug metabolism and pharmacokinetic services help in optimizing drug candidates for better efficacy and reduced toxicity.

**Process**: The market segmentation by process reflects the various stages involved in drug discovery, from target selection to candidate validation, each playing a crucial role in the development of new therapeutics.

**Therapeutic Area**: The therapeutic area segmentation highlights the diverse focus areas for drug discovery services, including neurology, diabetes, oncology, respiratory diseases, cardiovascular diseases, and others. Each therapeutic area presents unique challenges and opportunities for drug discovery efforts.

The global drug discovery services market is witnessing significant growth driven by increasing research and development activities in the pharmaceutical and biotechnology sectors. The demand for specialized services such as medicinal chemistry, biology, and preclinical testing is on the rise as companies seek

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Global Drug Discovery Services Market Landscape

Part 04: Global Drug Discovery Services Market Sizing

Part 05: Global Drug Discovery Services Market Segmentation By Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Key takeaways from the Drug Discovery Services Market report:

• Detailed considerate of Drug Discovery Services Market-particular drivers, Trends, constraints, Restraints, Opportunities and major micro markets.
• Comprehensive valuation of all prospects and threat in the
• In depth study of industry strategies for growth of the Drug Discovery Services Market-leading players.
• Drug Discovery Services Market latest innovations and major procedures.
• Favorable dip inside Vigorous high-tech and market latest trends remarkable the Market.
• Conclusive study about the growth conspiracy of Drug Discovery Services Market for forthcoming years.

Browse Trending Reports:

Thermal Imaging Cameras Market
Baby Food Market
Thin Film Encapsulation Market
Paper Coating Materials Market
Protein Engineering Market
Psoriasis Treatment Market
Whole Exome Sequencing Market
Std Diagnostics Market
Medication Delivery Systems Market
Lane Keep Assist System Market
Liquid Synthetic Rubber Market
Mainframe Market
Myxoid Round Cell Liposarcoma Drug Market
Hematology Analyzer Market
Low Differential Pressure Sensor Market
Biofuel Enzyme Market
Aroma Ingredients Market
Coconut Water Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"